This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Kidney, Subject name: Medicine
[{'content': 'Not a part of "Triple therapy" immunosuppression for post-renal transplant patient is: \nSelect and explain. \nA. Prednisone, B. Cyclosporine, C. Azathioprine, D. Belatacept', 'role': 'user'}, {'content': 'Answer: D \nExplanation: Ans. D. BelataceptBelatacept is not part of "Triple therapy" immunosuppression for post-renal transplant patient.* The most frequently used combination is triple therapy with- Prednisone- Calcineurin inhibitor (Tacrolimus - 1st line or Cyclosporine)- Antimetabolite (Mycophenolate mofetil or Azathioprine)* Mammalian TOR (mTOR) inhibitors can replace one of the last two agents.Note: More recently, the U.S. Food and Drug Administration (FDA) approved a new co-stimulatory blocking antibody (CD80 & CD86), belatacept, as a new strategy to prevent long-term calcineurin inhibitor toxicity. It is indicated for prophylaxis of organ rejection in patients who are EBV seropositive and receiving a kidney transplant.', 'role': 'assistant'}]